• Facebook
  • Twitter
Cancer World Archive
  • Magazine
Hometherapy

therapy

Metastatic prostate cancer: cabazitaxel shows quality of life benefits over both abiraterone and enzalutamide

News 6 October 2020 0

In addition to previously reported survival benefits, the taxane cabazitaxel improved quality of life in patients with advanced metastatic prostate cancer compared to the androgen signalling targeted inhibitors abiraterone and enzalutamide, reports the latest analysis [more]

In the US, costs of breast cancer treatments vary wildly

Featured, News 17 October 2016 0

An observational cohort study just published on the peer-reviewed journal Cancer concluded that the costs of breast cancer chemotherapy vary widely in the United States, even among treatment regimens with similar efficacy, and that patients [more]

Therapeutic options in recurrent glioblastoma – an update

Number 73-74

Impact Factor 12 September 2016 0

Standards of care are not yet defined for patients with recurrent glioblastoma. In this critical review, Katharina Seystahl and colleagues summarise the available literature for patients with recurrent (progressive) glioblastoma treated with repeat surgery, re-irradiation, [more]

Paris (France) 26-28/6/2016 – Innovative approaches to improve outcomes WIN 2016

Past events 17 May 2016 0

The WIN 2016 Symposium program will elaborate the overarching theme Innovative Approaches to Improve Cancer Patient Outcomes in four plenary sessions, divided over the two days of the meeting: New tools for early diagnosis, selecting therapies and monitoring [more]

LATEST PRINTED ISSUE

Latest news

  • Four steps to eliminating HPV infections across Europe: an ECCO call for EU action

    News 16 October 2020 0
    A new report underlines that vaccination, screening, treatment and public awareness, provide the cornerstone for eliminating human papillomavirus (HPV) in Europe. The report was published by The European [more]

Facebook

Twitter

Tweet di @CancerworldESO

© Copyright OncoDaily 2018 with all rights reserved - Credits -


Privacy Policy Cookie Policy